These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38970993)
1. Added IMPACT: The first successful natural birth using certolizumab in obstetric APS. Madenidou AV; Kither H; Dyball S; Bruce IN; Tower C Thromb Res; 2024 Jul; 241():109088. PubMed ID: 38970993 [No Abstract] [Full Text] [Related]
2. The treatment of anti-phospholipid syndrome: A comprehensive clinical approach. Chighizola CB; Andreoli L; Gerosa M; Tincani A; Ruffatti A; Meroni PL J Autoimmun; 2018 Jun; 90():1-27. PubMed ID: 29449131 [TBL] [Abstract][Full Text] [Related]
3. Impact of Inherited Thrombophilia in Women with Obstetric Antiphospholipid Syndrome: A Single-Center Study and Literature Review. Camacho Sáez B; Martínez-Taboada VM; Merino A; Comins-Boo A; González-Mesones B; Del Barrio-Longarela S; Riancho-Zarrabeitia L; López-Hoyos M; Hernández JL Biomedicines; 2024 May; 12(6):. PubMed ID: 38927381 [TBL] [Abstract][Full Text] [Related]
4. Obstetric Anti-phospholipid Syndrome: State of the Art. Gerardi MC; Fernandes MA; Tincani A; Andreoli L Curr Rheumatol Rep; 2018 Aug; 20(10):59. PubMed ID: 30105597 [TBL] [Abstract][Full Text] [Related]
5. A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome. Truglia S; Capozzi A; Mancuso S; Recalchi S; Spinelli FR; Perricone C; De Carolis C; Manganelli V; Riitano G; Garofalo T; Longo A; De Carolis S; Alessandri C; Misasi R; Valesini G; Sorice M; Conti F Front Immunol; 2018; 9():1678. PubMed ID: 30079071 [TBL] [Abstract][Full Text] [Related]
6. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Gerde M; Ibarra E; Mac Kenzie R; Fernandez Suarez C; Heer C; Alvarez R; Iglesias M; Balparda J; Beruti E; Rubinstein F Thromb Res; 2021 Oct; 206():104-110. PubMed ID: 34454240 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome. Arachchillage DR; Machin SJ; Mackie IJ; Cohen H Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976 [TBL] [Abstract][Full Text] [Related]
8. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
13. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Ernest JM; Marshburn PB; Kutteh WH Semin Reprod Med; 2011 Nov; 29(6):522-39. PubMed ID: 22161465 [TBL] [Abstract][Full Text] [Related]
14. Added value of antiphosphatidylserine/prothrombin antibodies in the workup of obstetric antiphospholipid syndrome: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies. Vandevelde A; Gris JC; Moore GW; Musiał J; Zuily S; Wahl D; Devreese KMJ J Thromb Haemost; 2023 Jul; 21(7):1981-1994. PubMed ID: 37061133 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of pregnancy complications and treatment in obstetric antiphospholipid syndrome in China. Zhou Z; Teng J; Sun Y; Liu H; Cheng X; Su Y; Yang C; Ye J Clin Rheumatol; 2019 Nov; 38(11):3161-3168. PubMed ID: 31290022 [TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of the antiphospholipid syndrome. Chaturvedi S; McCrae KR Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423 [TBL] [Abstract][Full Text] [Related]
18. Anti-β2GPI domain 1 antibodies stratify high risk of thrombosis and late pregnancy morbidity in a large cohort of Chinese patients with antiphospholipid syndrome. Liu T; Gu J; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Chi H; Zhou Z; Jia J; Wang Z; Zhou J; Norman GL; Wang X; Yang C; Shi H Thromb Res; 2020 Jan; 185():142-149. PubMed ID: 31816554 [TBL] [Abstract][Full Text] [Related]
19. Obstetric antiphospholipid syndrome is not associated with an increased risk of subclinical atherosclerosis. Bettiol A; Emmi G; Finocchi M; Silvestri E; Urban ML; Mattioli I; Scalera A; Lupoli R; Vannacci A; Di Minno MND; Prisco D Rheumatology (Oxford); 2020 Dec; 59(12):3709-3716. PubMed ID: 32388557 [TBL] [Abstract][Full Text] [Related]
20. Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study. Martínez-Taboada VM; Blanco-Olavarri P; Del Barrio-Longarela S; Riancho-Zarrabeitia L; Merino A; Comins-Boo A; López-Hoyos M; Hernández JL Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428506 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]